Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Dec 24 | BLCO Bausch + Lomb | Common Shares, No Par Value | Payment of exercise | Dispose F | No | No | 17.83 | 24,649 | 439.49 k | 528,988 |
23 Dec 24 | BLCO Bausch + Lomb | Common Shares, No Par Value | Payment of exercise | Dispose F | No | No | 17.83 | 73,782 | 1.32 mm | 553,637 |
12 Aug 24 | SKIN The Beauty Health Company | Class A Common Stock | Buy | Acquire P | No | No | 1.08 | 40,450 | 43.69 k | 5,921,769 |
5 Aug 24 | BLCO Bausch + Lomb | Common Shares, No Par Value | Grant | Acquire A | No | No | 0 | 32,250 | 0.00 | 627,419 |
5 Aug 24 | BLCO Bausch + Lomb | Common Shares, No Par Value | Buy | Acquire P | No | No | 15.661 | 32,250 | 505.07 k | 595,169 |
20 Jun 24 | SPRY ARS Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 7.73 | 40,000 | 309.20 k | 40,000 |
28 Feb 24 | BLCO Bausch + Lomb | Common Shares, No Par Value | Grant | Acquire A | No | No | 0 | 187,919 | 0.00 | 562,919 |
28 Feb 24 | BLCO Bausch + Lomb | NQSO Common Shares, No Par Value | Grant | Acquire A | No | No | 16.85 | 569,105 | 9.59 mm | 569,105 |